12/03/2024
3:31 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
4:00 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:19 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:08 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:11 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
3:59 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
3:42 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/04/2024
3:19 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
3:35 PM | MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/31/2024
10:55 AM | DIMENSIONAL FUND ADVISORS LP (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G | |
10/21/2024
3:48 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
3:16 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:03 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
3:30 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
4:00 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:03 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:16 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:18 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
3:19 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
3:41 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
3:48 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
3:20 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2024
3:24 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2024
3:28 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:14 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:18 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:53 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:15 PM | Supernus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/09/2024
3:09 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:05 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:08 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
7:03 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
4:00 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:00 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
4:01 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
5:39 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
4:00 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:23 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:00 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:01 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
4:28 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad) You don’t actually want to buy Bitcoin this time around.
That’s because there’s a better way to take advantage of this new bull market…
One market expert calls it Crypto’s Hidden Gem
And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin…
That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky…
This is a much safer and better approach to ride this years’ crypto bull run.
Because believe it or not…
The 2024 crypto bull run is one you DON’T want to miss. Click Here to get the full details about Crypto’s Hidden Gem |
02/14/2024
1:33 PM | ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
6:06 AM | MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G | |
02/05/2024
8:21 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
1:40 PM | BlackRock Inc. (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/10/2024
3:08 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
4:00 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
4:01 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free SUPN Stock Alerts